Precigen, Inc. (PGEN)
7.10
-0.04
(-0.56%)
USD |
NASDAQ |
Sep 04, 16:00
7.11
+0.01
(+0.14%)
After-Hours: 20:00
Precigen Cash and Short Term Investments (Annual) : 97.86M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 97.86M |
| December 31, 2024 | 97.91M |
| December 31, 2023 | 62.86M |
| December 31, 2022 | 99.29M |
| December 31, 2021 | 108.66M |
| December 31, 2020 | 100.12M |
| December 31, 2019 | 75.05M |
| December 31, 2018 | 223.86M |
| Date | Value |
|---|---|
| December 31, 2017 | 86.66M |
| December 31, 2016 | 244.20M |
| December 31, 2015 | 238.31M |
| December 31, 2014 | 115.96M |
| December 31, 2013 | 177.49M |
| December 31, 2012 | 10.66M |
| December 31, 2011 | 19.89M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Anika Therapeutics, Inc. | 57.48M |
| Geron Corp. | 359.80M |
| Neurocrine Biosciences, Inc. | 1.480B |
| Aldeyra Therapeutics, Inc. | 70.04M |
| Elicio Therapeutics, Inc. | 18.56M |